de Mendoza C - Search Results

1

Predictors of in-hospital mortality in HIV-infected patients with COVID-19.

Moreno-Torres V, de Mendoza C, Martínez-Urbistondo M, Mills P, Treviño A, de la Fuente S, Díaz de Santiago A, Calderón-Parra J, Pintos-Pascual I, Corpas M, Soriano V. Moreno-Torres V, et al. Among authors: de mendoza c, de la fuente s. QJM. 2023 Feb 14;116(1):57-62. doi: 10.1093/qjmed/hcac215. QJM. 2023. PMID: 36047831

2

Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.

Holguín A, de Mendoza C, Soriano V. Holguín A, et al. Among authors: de mendoza c. Eur J Clin Microbiol Infect Dis. 1999 Apr;18(4):256-9. doi: 10.1007/s100960050273. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10385013

3

Association between submaximal suppression of HIV replication and use of drug combinations without protease inhibitors.

de Mendoza C, Soriano V, González-Lahoz J. de Mendoza C, et al. Eur J Clin Microbiol Infect Dis. 1999 Aug;18(8):604-5. doi: 10.1007/s100960050358. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10517203 No abstract available.

4

Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy.

de Mendoza C, Soriano V, Pérez-Olmeda M, Rodés B, Casas E, González-Lahoz J. de Mendoza C, et al. J Hum Virol. 1999 Nov-Dec;2(6):344-9. J Hum Virol. 1999. PMID: 10774551

5

Efficacy and safety of didanosine and lamivudine both once daily plus indinavir in human immunodeficiency virus-infected patients.

de Mendoza C, Soriano V, Pérez-Olmeda M, Rodríguez-Rosado R, González-Lahoz J. de Mendoza C, et al. J Hum Virol. 2000 Nov-Dec;3(6):335-40. J Hum Virol. 2000. PMID: 11100914 Clinical Trial.

6

Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays.

de Mendoza C, Lu W, Machuca A, Sainz M, Castilla J, Soriano V. de Mendoza C, et al. J Med Virol. 2001 Jul;64(3):217-22. doi: 10.1002/jmv.1039. J Med Virol. 2001. PMID: 11424107

7

[HIV superinfection: clinical and biological implications].

Valer L, de Mendoza C, Soriano V. Valer L, et al. Among authors: de mendoza c. Med Clin (Barc). 2003 Jul 5;121(5):192-6. doi: 10.1016/s0025-7753(03)73899-8. Med Clin (Barc). 2003. PMID: 12867008 Review. Spanish.

8

[Mitochondrial damage by antiretrovirals: diagnosis and monitoring].

de Mendoza C, Blanco F, Soriano V. de Mendoza C, et al. Med Clin (Barc). 2003 Sep 13;121(8):310-5. doi: 10.1016/s0025-7753(03)73926-8. Med Clin (Barc). 2003. PMID: 14499088 Review. Spanish.

9

[HIV-2 and HTLV-1/2 infections in Spain].

Treviño A, Soriano V; Grupo Español para el Estudio del VIH-2 y HTLV-1/2. Treviño A, et al. Med Clin (Barc). 2010 Jun 12;135(2):67-9. doi: 10.1016/j.medcli.2009.04.024. Epub 2009 Jun 27. Med Clin (Barc). 2010. PMID: 19560171 Spanish. No abstract available.

10

[Resistance to integrase inhibitors].

Garrido C, de Mendoza C, Soriano V. Garrido C, et al. Among authors: de mendoza c. Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 12:40-6. doi: 10.1016/s0213-005x(08)76572-8. Enferm Infecc Microbiol Clin. 2008. PMID: 19572425 Review. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

289 results

Search Page